Researchers are shining a light on cancer cells’ energy centers – literally – to damage these power sources and trigger widespread cancer cell death.
Leo Pharma agrees to acquire Timber Pharmaceuticals
TMB-001 is intended for the treatment of congenital ichthyosis, a rare skin condition. Credit: Kwangmoozaa / Shutterstock.com. Leo Pharma has entered an agreement for the acquisition of
August 22, 2023